Wegovy is another brand-name medication of semaglutide that is specifically approved for weight loss in obese (BMI 30kg/m or greater) and overweight patients (BMI 27/m or greater) with at least one obesity related health condition (such as heart disease, hyperlipidemia, hypertension, and hypercholesterolemia) and managing metabolic dysfunction-associated steatohepatitis (MASH) in patients with moderate to advanced liver fibrosis
If you miss a dose and your next scheduled dose is more than 2 days away, take the missed dose as soon as possible
If tirzepatide is not effective, mazdutide may work better due to its different secondary mechanism, and vice versa
The Bottom Line GHK-Cu injection frequency follows a simple default: once daily, five days on, two days off, for 4 to 12 weeks
Asadi S, Gholami MS, Siassi F, Qorbani M, Sotoudeh G